Ausgabe 8/2018
Inhalt (10 Artikel)
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias
Chris J. Packard
Open Access
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?
I. Karalis, J. W. Jukema
Ischemic Heart Disease (D Mukherjee, Section Editor)
Cardiovascular and Renal Outcomes of Newer Anti-Diabetic Medications in High-Risk Patients
Lima Lawrence, Venu Menon, Sangeeta Kashyap
Ischemic Heart Disease (D Mukherjee, Section Editor)
Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction
Matthew Liakos, Puja B. Parikh
Pericardial Disease (AL Klein, Section Editor)
Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases
Giacomo Emmi, Maria Letizia Urban, Massimo Imazio, Marco Gattorno, Silvia Maestroni, Giuseppe Lopalco, Luca Cantarini, Domenico Prisco, Antonio Brucato
Pericardial Disease (AL Klein, Section Editor)
Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine
Aldo L. Schenone, Venu Menon
Cardio-Oncology (SA Francis and RB Morgan, Section Editors)
Update on Incorporating Biomarkers with Imaging Findings for the Detection and Management of Cardiotoxicity
Neha Quatromoni, Marielle Scherrer-Crosbie
Cardio-Oncology (SA Francis and RB Morgan, Section Editors)
Cardiovascular Autonomic Dysfunction in Patients with Cancer
Ben G. T. Coumbe, John D. Groarke
Regenerative Medicine (SM Wu, Section Editor)
Cardiomyocyte Proliferation for Therapeutic Regeneration
John P. Leach, James F. Martin
Congenital Heart Disease (RA Krasuski, Section Editor)
Long-term Management of the Arterial Switch Patient
Jared Kirzner, Altaf Pirmohamed, Jonathan Ginns, Harsimran S. Singh